Experts at Evernorth Outcomes event stress the importance of an integrated data model to improve health and lower costs
During the closing session of the Evernorth Outcomes client event, panelists discussed the power of integrating pharmacy, medical, and behavioral care and looked ahead to explore the biggest opportuni...
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreDrug Lists 101 – Supporting Access to Safe and Effective Medications
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
Read MoreEvernorth Enters Strategic Collaboration with VillageMD to Accelerate Value-Based Services and Care Delivery Strategy
Read More
Understanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreGame changer: Three things to know about interchangeable biosimilars
The first interchangeable biosimilar is now available. Here’s what plans need to know about these products, which – like generics – can be substituted at the pharmacy.
Read MoreMeet Joan Harvey, President, Evernorth Care Solutions
Harvey talks about her career, how her dad’s restaurant molded her into the professional she is today, and what it’s like being a woman in the business world.
Read MoreExpress Scripts continues efforts to lower drug costs and ensure streamlined patient access to innovative biosimilars
Read More
PBM clients agree: Protect our pharmacy benefit tools
Express Scripts by Evernorth recently polled a group of more than 200 health benefit experts about the policy proposals being considered by Congress.
Read MoreExpress Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More